Prices and Markets

Aberdeen Emerging Markets – Focused on returns

The managers of Aberdeen Emerging Markets (AEMC) are optimistic about the prospects for the company. Strong performance last year has not yet translated into a reduction in the discount that the share price trades at relative to the asset value, but if outperformance can be maintained, this should follow in time. Investors might also be comforted by AEMC’s much lower volatility of returns compared to its peers and its benchmark…. Read more

The managers feel that AEMC offers investors a ‘one-stop shop’ for those looking for emerging markets exposure. AEMC’s portfolio would be hard for most investors to replicate without considerable effort. It also benefits from an experienced and well-resourced team, backed by the resources of Aberdeen Standard Investments.


Before the emergence of COVID-19 (the coronavirus), the managers felt that 2020 could be the year in which emerging market earnings turned a corner. Investors’ expectations and valuations are more realistic now and recent market falls could be a buying opportunity.

Aims for consistent outperformance of MSCI Emerging Markets Index

AEMC invests in a carefully-selected portfolio of both closed- and open-ended funds, providing a diversified exposure to emerging economies. It aims to achieve consistent returns for its shareholders in excess of the MSCI Emerging Markets Net Total Return Index in sterling terms.#

Read more

NB: Marten & Co was paid to produce this note on Aberdeen Emerging Markets Investment Company Limited and it is for information purposes only. It is not intended to
encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading
name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors
categorised as Retail Clients under the rules of the Financial Conduct Authority.

Edward Marten

Edward Marten is MD of investor research company QuotedData. They provide free information for investors who find it hard to access high-quality, reliable, equity research on UK and European-listed companies. This is a QuotedData release.

Published by